CBP501, Cisplatin and Nivolumab in Advanced Refractory Tumors

Clinical trial NCT03113188 · COMPLETED

Trial details

NCT number: NCT03113188
Sponsor: CanBas Co. Ltd.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Solid Tumors

Start date: 2017-10-25
Primary completion: 2021-02-15
Enrollment: 47

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.